open.spotify.com
Mar 17, 2026, 15:43
How Clinicians Navigate the Challenge of Balancing Clotting and Bleeding in CAD – Vasculearn Network
Vasculearn Network shared a post on LinkedIn:
“Antithrombotic therapy in coronary artery disease isn’t one-size-fits-all anymore.
Heather M. Johnson, Ty J. Gluckman and Davide Capodanno come together in the latest episode of Clot, Clot, Who’s There? to chat about how clinicians are navigating the everyday challenge of balancing clotting and bleeding risk.
From the evolving role of aspirin to P2Y12 monotherapy, dual pathway inhibition, and managing CAD with AFib, the conversation highlights a simple shift in thinking:
Less of ‘What should everyone get?’
More of ‘What’s right for the patient in front of me?’
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 11:38Maria Hadjidemetriou: The Patient Perspective in Thalassemia Care
-
Aug 11, 2026, 11:04Wolfgang Miesbach: The Critical Need for Tailored Dosing in VWD
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care